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ABSTRACT 
 
The ion release profiles and bioactivity of a series of Ti containing glass polyalkenoate cements 
(GPCs). Characterization revealed each material to be amorphous with a Tg in the region of 650-
660ºC. The network connectivity decreased (1.83-1.35) with the addition of TiO2 which was also 
evident with analysis by X-ray Photoelectron Spectroscopy (XPS). Ion release from cements 
were determined using Atomic Absorption Spectroscopy (AAS) for zinc (Zn
2+
), calcium (Ca
2+
), 
strontium (Sr
2+
), Silica (Si
4+
) and titanium (Ti
4+
). Ions such as Zn
2+
 (0.1-2.0 mg/L), Ca
2+
 (2.0-8.3 
mg/L,) Sr
2+
 (0.1-3.9 mg/L), and Si
4+
 (14-90 mg/L) were tested over 1-30 days. No Ti
4+
 release 
was detected. Simulated body fluid (SBF) revealed a CaP surface layer on each cement while 
cell culture testing of cement liquid extracts with TW-Z (5 mol% TiO2) produced the highest cell 
viability (161%) after 30 days. Direct contact testing of discs resulted in a decrease in cell 
viability of each cement tested. 
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1. INTRODUCTION 
 Glass Polyalkenoate Cements (GPC) have generated considerable interest recently as 
potential materials for the replacement of bone. Bone augmentation is required in cases where it 
is compromised by for example, osteoporosis
[1]
 and osteomyelitis
[2]
. Surgical procedures that 
require augmentation include Total Hip Replacement (THR)
[3]
 which utilizes bone cement to 
secure the bond between the metallic implant and the bone
[4]
, Vertebroplasty and Kyphoplasty 
where cements restore vertebral body height and offer mechanical stability
[5, 6]
. However a 
number of problems exist with the gold standard PMMA based bone cements. They do not form 
a chemical bond with the surrounding bone
[7, 8]
, and experience up to 7% volumetric shrinkage
[9] 
upon setting which contributes to aseptic loosening and subsequently implant failure. A setting 
exotherm of up to 120
o
C can also occur damaging surrounding tissues. Studies have determined 
that temperatures above 60
o
C results in permanent cessation of blood flow in the tissue
[10]
 and 
that coagulation of proteins and thermal necrosis of bone cells begins at 56
o
C
[11]
. Leaching of 
monomers and the generation of free radicals during setting can also have a negative effect on 
surrounding tissues and immune response
 [12, 13]
. Increasing the bioactivity of bone cements has 
generated considerable interest recently as PMMA based cements are typically described as 
being bioinert in vivo. Calcium phosphate cements exhibit a degree of bioactivity
 [14]
, however 
extended setting times
 [15, 16]
 and low mechanical properties
 [17]
 have limited their use in load-
bearing orthopedic applications.  
 GPCs have a number of attractive properties relevant for orthopedics. They can 
chemically bond to both bone and surgical metals
[18]
, and can be tailored to release beneficial 
quantities of ions which can have positive effects in vivo
[18, 19]
. In this work, a titanium (Ti) 
substituted GPC was formulated as Ti is commonly used in both medical and dental applications. 
It is used for metallic implant materials in orthopedics
 [3]
, for crown and bridges in dentistry
 [20]
 
and also has oral-maxillofacial applications
 [21]
. Ti-based materials are also known to form a CaP 
surface layer when immersed in simulated body fluids
 [22, 23]
. The presence of this layer is 
reported to be a pre-requisite to bone bonding
 [23]
, which is beneficial as it results in implant 
stabilization. Additional components of these Ti-GPCs include zinc (Zn), strontium (Sr) and 
calcium (Ca) which all have been reported in the literature to have positive metabolic effects on 
bone
[24-28]
, in addition Zn has also been reported to impart an antibacterial nature to the 
material
[29, 30]
. Previous work on these cements has resulted in increasing the handling and 
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mechanical properties compared to a Ti-free GPC of similar composition
[31]
. Characterization of 
the Ti-glass phase has also revealed that the addition of TiO2 results in an increased 
concentration of Si-O-NBO species
 [32]
. In relation to bioactivity, network modifying alkali and 
alkali earth cations in the glass can disrupt the continuity of the glass network due to the 
breaking of some of the Si-O-Si groups leading to the formation of Si-O-NBO species
 [33]
. The 
presence of these Si-O-NBO groups favors the ion exchange process where dissolution of the 
soluble silica content results in the formation of a SiO2 rich surface layer and consequently Si-
OH groups, and also the release of cations from the glass surface
[33]
.  
This study expands on previous work on these cements that were found to have increased 
mechanical and handling properties compared to a control cement (BT 101). This study 
determines the ion release profiles, the ion release rates effect on the cement structure, and the 
bioactive response in Simulated Body Fluid (SBF) and cell culture.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 
 
2. MATERIALS & METHODS 
2.1 Glass Synthesis 
Four glass compositions were formulated for this study with the principal aim being to 
investigate the substitution of Si with Ti throughout the glass series. BT 101 was used as a 
control, and glasses denoted TW-X, TW-Y and TW-Z contain incremental concentrations of Ti 
at the expense of Si (table 1). Glasses were prepared by weighing out appropriate amounts of 
analytical grade reagents (Sigma-Aldrich, Dublin, Ireland) and ball milling (1 h). The mix was 
then oven dried (100ºC, 1 h), fired (1500ºC, 1 h) in a platinum crucible and shock quenched  in 
water. The resulting frit was dried, ground and sieved to retrieve a glass powder with a maximum 
particle size of 45μm.  
 
Table 1. Ti glass compositions. 
 
 BT 101 TW-X TW-Y TW-Z 
SiO2 0.480 0.464 0.448 0.430 
TiO2 0.000 0.016 0.032 0.050 
ZnO 0.360 0.360 0.360 0.360 
CaO 0.120 0.120 0.120 0.120 
SrO 0.040 0.040 0.040 0.040 
 
 
2.2 Glass Characterisation 
 
2.2.1  X-Ray Diffraction (XRD) 
 
Diffraction patterns were collected using a Philips Xpert MPD Pro 3040/60 X-ray 
Diffraction Unit (Philips, Netherlands). Disc samples (32mm Ø x 3mm) were prepared by 
pressing a selected glass powder (<45μm) into a backing of ethyl cellulose (8 tonnes, 30s). 
Samples were then placed on spring-back stainless steel holders with a 10mm mask and were 
analysed using Cu Kα radiation. A generator voltage of 40kV and a tube current of 35mA were 
employed. Diffractograms were collected in the range 5˚<2θ<80˚, at a scan step size 0.0083˚ and 
a step time of 10 s. Any crystalline phases present were identified using Joint Committee for 
Powder Diffraction Studies (JCPDS) standard diffraction patterns. 
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2.2.2  Differential Thermal Analysis (DTA)  
 
A combined differential thermal analyser-thermal gravimetric analyser (DTA-TGA) 
(Stanton Redcroft STA 1640, Rheometric Scientific, Epsom, UK) was used to measure the glass 
transition temperature (Tg) for both glasses. A heating rate of 10
o
C min
-1
 was employed using an 
air atmosphere with alumina in a matched platinum crucible as a reference. Sample 
measurements were carried out every six seconds between 30˚C and 1000˚C. 
 
2.2.3 Network Connectivity 
 
The network connectivity (NC) of the glasses was calculated with equation 1 using the 
molar compositions of the glass. Network connectivity calculations were performed assuming 
that titanium performs as a network former and also as a network modifier. 
 
 
SpeciesBridgingNoTotal
NBOsNoBOsNoNC
.
..             Equation 1 
Where: 
NC = Network Connectivity 
BO = Bridging Oxygens 
NBO = Non-Bridging Oxygens 
 
 
2.2.4 X-Ray Photoelectron Spectroscopy  
 
X-ray Photoelectron Spectroscopy was performed in a Kratos AXIS 165 spectrometer 
using monochromatic Al Kα radiation (hυ =1486.6 eV) and a constant pass energy of 20 eV. 
Glass rods with dimensions of 15 × 3 × 3 mm were produced from the melt and fractured under 
vacuum (~ 2 × 10
-8
 torr) to create pristine surfaces with minimum contamination. Surface 
charging was minimised by flooding the surface with low energy electrons. The C 1s peak of 
adventitious carbon at 284.8 eV was used as a charge reference to determine the binding 
energies. For peak fitting, a mixed Gaussian-Lorenzian function with a Shirely type background 
subtraction was used. 
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2.3 Cement Preparation 
 Cements were prepared by thoroughly mixing the glass powders (<45m) with E11 
polyacrylic acid (PAA - Mw 210,000, <90m, Advanced Healthcare Limited, Kent, UK) and 
sterile water on a glass plate.  The cements were formulated at P:L ratio of 2:1.5 with 50wt% 
additions of PAA, where 1g of glass powder was mixed with 0.37g PAA and 0.37ml water. 
Complete mixing was undertaken within 20 seconds for each disc. Cement discs were made by 
placing the viscous cements in 8ø x 2mm split ring moulds, clamped between two polyethylene 
plates and allowed to set in an oven at 37ºC for 1 hour prior to use. Cements were used 
immediately after setting (for ion release, SBF testing and cell culture) with minimal exposure to 
air. Cements from each formulation were produced identically and in triplicate for each test.  
 
2.4 Preparation of Extracts  
 
Approximately 50g of each glass (BT 101, TW-X, TW-Y, TW-Z) was sterilized using γ-
irradiation at 25kGray (Isotron ltd, Mayo, Ireland) prior to forming cements. Tissue culture water 
(Sigma Aldrich, Dublin, Ireland) was selected as the solvent to prepare liquid extracts for ion 
release, SBF testing and cell culture analysis. The calculated surface area of each cement sample 
was used to determine the volume of extract required using equation 2. 
10
SaVs        Equation 2 
Vs = volume of extract used. 
Sa = exposed surface area of the cement disc.  
 
For cytotoxicity analysis both cements and extracts were used for analysis. Cement samples 
(n=3) were aseptically immersed in appropriate volumes of sterile tissue culture water and 
agitated at (37˚C ± 2˚C) for 1, 7 and 30 days. For cytotoxicity testing 100 µl aliquots (n=3) of 
extract were removed after each time period. Additionally cements were incubated in cell culture 
wells and tested after 24 hours for direct contact testing. 
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2.5  Ion Release Profiles 
 
The Zinc (Zn), Strontium (Sr), Silica (Si), Calcium (Ca) and Titanium (Ti) ion 
concentration of the water extracts that contained the cement discs for each formulation (n=3), 
were determined over 1, 7 and 30 days, and were measured using an Atomic Absorption 
Spectrometer (AAS) (Varian SpectrAA-44-400) and the conditions are listed in table 2. 
 
Table 2. AAS operating parameters. 
 
 Zn Sr Na Ca 
Lamp Current (mA) 5 10 5 10 
Fuel Acetylene Acetylene Acetylene Acetylene 
Support Nitrous Oxide Nitrous Oxide Air Nitrous Oxide 
Wavelenght (nm) 213.9 460.7 330.2 239.9 
 
 
Standard solutions were used for calibration of the system. NaCl was added to Sr and Na while 
LaCl was added to Ca to inhibit ionization of these elements. Three measurements were taken 
from each aliquot in order to determine the mean concentration of each element for each 
incubation period. 
2.6  Surface Area Determination 
 
In order to determine changes in surface area of the cements over time the advanced 
surface area and porosimetry, ASAP 2010 System analyser (Micrometrics Instrument 
Corporation, Norcross, USA) was employed. Approximately 60 mg of each set cement disc 
(n=3) used for the ion release study was analysed with the addition of a control disc (not 
immersed in water, t-0). So for each formulation the SA was tested at t-0, 1, 7 and 30 days. 
Specific surface area changes were conducted using the Brunauer- Emmett-Teller (BET) method. 
 
2.7 Simulated Body Fluid Trial 
 
Simulated body fluid (SBF) was produced in accordance with the procedure outlined by 
Kokubo et al
[23]
. The composition of SBF is outlined in table 3. The reagents were dissolved in 
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order, from reagent 1–9, in 500 ml of purified water using a magnetic stirrer. The solution was 
maintained at 36.5 ˚C. 1 M-HCl was titrated to adjust the pH of the SBF to 7.4. Purified water 
was then used to adjust the volume of the solution up to 1L. Cement discs (n = 2) were 
immersed in concentrations of SBF as determined by equation 2 and were subsequently stored in 
for 1, 7 and 30 days in an incubator at 37˚C. A JOEL JSM-840 scanning electron microscope 
equipped with a Princeton Gamma Tech (PGT) Energy Dispersive X-ray (EDX) system was 
used to obtain secondary electron images and carry out chemical analysis of the surface of 
cement discs. All EDX spectra were collected at 20 kV, using a beam current of 0.26 nA. 
Quantitative EDX converted the collected spectra into concentration data by using standard 
reference spectra obtained from pure elements under similar operating parameters. 
 
Table 3. Composition of SBF. 
 
Order Reagent 
Required 
Amount 
1 NaCl 7.996g 
2 NaHCO3 0.35g 
3 KCl 0.224g 
4 K2HPO4.3H2O 0.228g 
5 MgCl2.6H2O 0.305g 
6 1M-HCl 40ml 
7 CaCl2 0.278g 
8 Na2SO4 0.071g 
9 NH2C(CH2OH)3 6.057g 
 
 
 
2.8 In vitro assessment of Cements and Extracts 
 
The established cell line L-929 (American Type Culture collection CCL 1 fibroblast, 
NCTC clone 929) was used in this study as required by ISO10993 part 5
[34]
. Cells were 
maintained on a regular feeding regime in a cell culture incubator at 37˚C/5% CO2/95% air 
atmosphere. Cells were seeded into 24 well plates at a density of 10,000 cells per well and 
incubated for 24 hours prior to testing with both extracts and cement discs. The culture media 
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used was M199 media (Sigma Aldrich, Ireland) supplemented with 10% foetal bovine serum 
(Sigma Aldrich, Ireland) and 1% (2 mM) L-glutamine (Sigma Aldrich, Ireland). The cytotoxicity 
of cement extracts was evaluated using the Methyl Tetrazolium (MTT) assay in 24 well plates. 
Extracts (100 µl) of undiluted sample (n=3) were added into wells containing L929 cells in 
culture medium (1 ml) after 1, 7 and 30 day exposure to cement discs. Also cement discs (n=3) 
were placed in the plate wells and were tested after 24 h (direct contact). Each of the prepared 
plates was incubated for 24 h at 37˚C/5% CO2. The MTT assay was then added in an amount 
equal to 10% of the culture medium volume/well. The cultures were then re-incubated for a 
further 2 h (37˚C/5% CO2). Next, the cultures were removed from the incubator and the resultant 
formazan crystals were dissolved by adding an amount of MTT Solubilization Solution (10% 
Triton x-100 in Acidic Isopropanol. (0.1 n HCI)) equal to the original culture medium volume. 
Once the crystals were fully dissolved, the absorbance was measured at a wavelength of 570 nm. 
Aliquots (100 µl) of tissue culture water were used as controls, and cells were assumed to have 
metabolic activities of 100%. Cement discs and extracts in media without cells were tested and 
found not to interfere with the MTT assay. 
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3. RESULTS & DISCUSSION 
The bioactive response of a series of Ti substituted GPCs was evaluated to expand previous 
work which described the glass phase characterization
 [32]
, mechanical properties and setting of 
these cements
 [31]. Initial testing was performed on the glass both before and after γ-sterilization. 
Characterization of the glass phase of this cement series was carried out using X-ray Diffraction 
(XRD), Differential Thermal Analysis (DTA) and Network Connectivity (NC) calculations and 
X-ray Photoelectron Spectroscopy (XPS). X-ray diffraction patterns are presented in figure 1. 
 
 
 
Figure 1. XRD of a.) normal glass and b.) irradiated glass. 
 
From figure 1 it can be seen that each material was found to be amorphous (BT 101 – TW-
Z), both before and after γ-sterilization. DTA revealed that Tg for the control glass, (BT 101) was 
found to be 657°C (figure 2a). Little change in Tg was found with the addition of up to 5 mol% 
TiO2. TW-X, TW-Y and TW-Z were found to have a Tg of 654°C, 656°C and 655°C 
respectfully. γ-sterilization was also found to have little effect on the Tg of the glass series, where 
post-sterilization the Tg were 657°C, 654°C, 661°C and 650°C for BT 101 TW-X, TW-Y and 
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TW-Z respectively. This supports earlier studies on the effect of γ-sterilization on similar 
bioactive glasses where no structural changes were found
 [35]
. 
 
 
Figure 2. a.) Glass transition temperature of normal and irradiated glass & b.) network connectivity of glass series. 
 
The network connectivity of the glass series was found to decrease from 1.83 to 1.69, 1.54 
and 1.35 for BT 101, TW-X, TW-Y and TW-Z respectively, as the TiO2 concentration in the 
glass increased (figure 2b). Previous work on similar glass compositions determined that Ti acted 
as a network modifier within the glass, where it forms 6-fold octahedral groups resulting in an 
increase in the concentration of Non-Bridging Oxygen (NBO) groups
 [32]
.  
XPS was performed to distinguish between bridging (BO) and non-bridging oxygens. Figure 
3a shows a high resolution O 1s spectrum from BT 101, while figure 3b shows O 1s from TW-Z. 
Asymmetry in the peak suggests the existence of two states for oxygen. Since the specimen 
glasses are cleaved in vacuum, the peak can be fitted with two component peaks at 530.6 and 
531.9 eV to represent the NBO and BO respectively. Addition of TiO2 in TW-Z, shifts the NBO 
peak to lower binding energy from 530.8 eV (BT101) to 530.6 eV and increases the ratio of 
NBO/BO from 1.2 to 1.9 as given in table in figure 3c. Peak fitting parameters and constraints 
are described elsewhere
 [32]
. 
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Figure 3. O 1s spectrum of a.) BT101, b.) TW-Z and c). XPS data table. 
 
Previous studies determined that the dissolution and subsequent bioactivity of the glass 
surface is directly related to the concentration of NBO species. The addition of alkali and alkali 
earth cations (Na
+
, K
+
, Ca
2+
) act as network modifiers that disrupt the continuity of the glassy 
network due to the breaking of some of the Si-O-Si bonds leading to the formation of Si-O-
NBO
[33]
. In this study, peak shift in O 1s to lower binding energy and increased relative amount 
of NBO in TW-Z and in subsequent glasses with increasing TiO2 content 
[32]
, is indicative of 
adding modifying cations to the glass. It is reported that the ion exchange process is favored by 
the presence of Si-O-NBO groups where the addition of alkali/alkali earth ions creates a larger 
number of these NBO groups in the glass structure leading to a higher dissolution rate of the 
silica
 [33]
.  
Ion release profiles from each element from the cements were determined. It was found the 
Si, Zn, Ca, and Sr are being released from the cements, however, Ti is not being released or is 
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released in levels below the detection limit of the instrument. The ion release profiles for the 
cements are presented in figure 4. 
 
Figure 4. Ion release profiles of a.) silica, b.) zinc, c.) calcium and d.) strontium.  
 
It can be seen from figure 4a that Si release levels reached approximately 14 mg/L at 1 day 
and comparisons between cements found there to be no significant difference. At 7 days, release 
levels reached 30-40 mg/L with significant change (p=0.014) being evident between TW-Y (32 
mg/L) and TW-Z (37 mg/L). After 30 days, Si release levels increased to within the region of 60-
90 mg/L. BT 101 (61 mg/L) and TW-X (68 mg/L) showed no significant change, while both 
TW-Y (78 mg/L, p=0.034) and TW-Z (86 mg/L, p=0.034) showed a significant increase in Si 
release. This suggests the addition of Ti to the glasses facilitates an increase in the release of Si 
from the cements; however this only occurs after 30 days immersion in an aqueous medium. This 
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may be attributed to Ti depolymerising the silicate network forming NBO species. The formation 
of NBOs in glasses is known to greatly contribute to ion exchange and bioactivity
 [33]
. It is also 
evident that each cement showed a cumulative increase in Si levels with respect to maturation 
particularly considering TW-Z were it increased from 15 mg/L to 37 mg/L (p=0.014) between 1 
and 7 days, and from 37 mg/L to 86 mg/L (p=0.001) between 7 and 30 days. Figure 4b shows 
the Zn release rates over the same time period. Zn was found to be released in much lower levels 
than Si, ranging from 0.1-2.0 mg/L over 1-30 days. At 1 day, Zn release was found to reduce 
with the addition of Ti through the cement series. Zn levels significantly reduced (p=0.023) from 
0.6 mg/L (BT 101) to 0.1 mg/L (TW-Z). A similar trend was seen at 7 days where Zn reduced 
from 1.8 mg/L (BT 101) to 0.7 mg/L (TW-Z) (p=0.0001). At 30 days the Zn levels increased in 
the Ti containing cements to similar levels presented by BT 101 (2.0 mg/L), no significant 
change was found between cements at this time period. However in a similar fashion to Si, the 
concentration of Zn was higher at each time interval as a result of the cumulative Zn release, 
particularly considering TW-Z were it increased from 0.1 mg/L to 0.7 mg/L (p=0.010) between 
1 and 7 days, and from 0.7 mg/L to 1.8 mg/L (p=0.011) between 7 and 30 days. 
From figure 4c it can be seen that Ca release showed relatively little change between each of 
the cements. Ca release levels ranged from 2.0 mg/L (TW-Z, 1 day) to 8.3 mg/L (TW-Y, 30 
days). For each cement the Ca levels were found to be higher at each time interval. The most 
prominent increase in Ca release being for BT101 where Ca levels increased from 2.1 mg/L to 
5.6 mg/L (p=0.015) between 1 and 7 days, and from 5.6 mg/L to 8.2 mg/L (p=0.035) between 7 
and 30 days. Figure 4b shows the Sr release from the cements. Sr release ranged from 0.15 mg/L 
(TW-Z, 1 day) to 3.9 mg/L (BT 101, 30 days). It can be seen that the Sr release showed a general 
decrease when comparing BT 101 with the Ti containing cements. At 1 day the Sr release 
significantly decreased (p=0.013) from 0.7 mg/L (BT 101) to 0.15 mg/L (TW-Z), at 7 days 
(p=0.0001) 2.9 mg/L (BT 101) to 0.6 mg/L (TW-Z) and at 30 days (p=0.0001) 3.9 mg/L (BT 
101) to 1.3 mg/L (TW-Z). In a similar trend to each of the other ions, in each instance there was 
a higher concentration of ions detected at each time period, the most prevalent being with the 
control cement, BT 101. Sr levels increased from 0.7 mg/L to 2.9 mg/L (p=0.002) between 1 and 
7 days, and from 2.9 mg/L to 3.9 mg/L (p=0.017) between 7 and 30 days. The decrease in the Sr 
release from the cement may be due to structures formed within the glass with the addition of Ti. 
Previous work on these glass formulations revealed that the Ti acts and a network modifying 
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cation in the glass forming both tetrahedral (4-fold) and a number of octahedral (6-fold) 
structures. Excessive oxygen in octahedral structures requires charge compensation, which may 
be one possible explanation for the reduced Sr concentration with the addition of Ti
 [32]
. Overall 
cumulative ion release was found to be higher at each time period tested, however based on a 
daily release rate, ion release was found to reduce. This trend is valid as the cements structure 
matures and sets resulting in a lower solubility.  
The surface area (SA) of each of the cements was determined using the BET method. BET 
was used in order to determine any changes in SA of the cements with exposure time in an 
aqueous environment, which will be related to the composition of the starting glass. Figure 5 
shows the SA of the cements over 1 & 30 days.  
 
 
Figure 5. Surface area of cements series as determined by ASAP. 
 
Surface area measurements determined BT 101 to have an initial SA of 63 m
2
/g which increased 
to 95 m
2
/g at 1 day and was found to decrease to 24 m
2
/g after 30 days. The Ti containing 
cements exhibited lower SA than BT 101, particularly in the case of TW-Z, where initially the 
SA was 48 m
2
/g
 
which increased slightly over 1 day (54 m
2
/g) and 7 day (56 m
2
/g) and reduced 
to 41 m
2
/g after 30 days. However a general decrease in the SA can be observed with the 
increase in TiO2 concentration. This is likely due to the open porosity, solubility and particulate 
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composition of the set cements. A slight increase in the SA was observed in each of the cements 
after 1 day immersion in water. This is due to the dissolution of the PAA within the cement 
matrix resulting in open porosity, thus liberating ions bound within the cement structure. In the 
case of BT 101 it seems particle dissolution occurs at a greater extent and that it may be more 
soluble when compared to the Ti containing cements. This could be due to incomplete setting by 
a reduction in the concentration/formation of COO
-
Ca
2+
/Sr
2+ 
polyacrylates. Previous work on 
these materials found that the Ti cements are more structurally stable when set than the Ti free 
cement, BT 101, which is the likely reason for the reduced loss in SA as compared to BT 101
[31]
. 
The higher concentration of NBO in the TW-Z glass phase will permit greater liberation of 
cations during the setting process which will subsequently facilitate a more matured set cement 
and resulting in less solubility. Form each of the Ti containing cements it can be seen that the 
surface area reduced as the Ti concentration increased, suggesting that the addition of Ti 
increases crosslinking within the cement, reducing solubility. 
The bioactivity of the cements was determined using both Simulated body Fluid (SBF) and 
cell culture. SBF testing is used to determine a material’s response in a physiological medium 
substitute. SBF was developed by Kokubo as a synthetic form of blood plasma where it contains 
a similar ionic composition
[36]
. Precipitation of Ca
2+
 and PO4
2-
 from this ionic solution to form a 
CaP surface layer on the materials surface in SBF is seen as a precursor to bone bonding in 
vivo
[37-39]
.  
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Figure 6. SBF testing for a.) BT 101, b.) TW-X, c.) TW-Y and d.) TW-Z. over 1-30 days. 
 
From figure 6 it can be seen that BT 101 exhibited a CaP surface layer (SEM & EDS) after 1 
day, and increased up to 30 days. This trend can also be observed in each of the Ti containing 
cements (TW-X, TW-Y and TW-Z). It is likely that surface deposition occurs due to the 
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presence of Ca and Si in the glass phase. The release of Ca
2+
 from the cements increases the Ca
2+
 
concentration in the SBF and upon reaching the saturation limit, precipitation occurs and the 
negatively charged surface binds Ca
2+
 and PO4
2-
. The soluble silica content forms the negatively 
charged Si–OH- groups on the surface of the material [39, 40]. It is also evident that there is a high 
concentration of Zn
2+
 released from the cement which has previously been found to inhibit the 
crystallization of this surface layer to hydroxyapatite (HA)
[41]
. SBF testing revealed that surface 
precipitation of CaP was present on each of the cements at each time period.  
Cell culture testing was performed using both cement discs and water based extracts released 
from the cements. For direct contact testing (figure 7a) it was found that there was a significant 
decrease in the viability of cells with each of the cements when compared to the control cells.  
BT 101 (2%, P=0.0001), TW-X (1.2%, P=0.0001), TW-Y (0.5%, P=0.0001), TW-Z (0.4%, 
P=0.0001). This is due to the gradual leaching of ions from the cements over 24 hours into the 
enclosed environment of the cell culture wells. Ions leached from the cements (Ca
2+
, Sr
2+
, Zn
2+
, 
Si
2+
) quickly reach levels that are toxic to the cells resulting in a reduction in cell viability. There 
was found to be no significant change when comparing each of the cements. 
 
 
Figure 7. Cell culture from cement extracts after 1, 7 and 30 days, and insert a.) Cement direct contact in cell 
culture. 
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Cement extracts were tested for each cement over 1, 7 and 30 days. When comparing each of 
the cements to the control cells at 1 day, there was found to be no significant change in cell 
viability. A similar trend was observed at 7 days. At 30 days however both BT 101 (142%, 
p=0.001) and TW-Z (161%, p=0.0001) showed a significant increase in the cell viability. This 
suggests that solutions produced after 30 days are lower in toxicity, and are at levels favorable 
for cell proliferation. When considering the effect of maturation on each of the cements cell 
viability there was a general increase, however this only reached significance in a number of 
instances , BT 101 (1 & 30 days, p=0.020) and TW-Z (1 & 30 days, p=0.0001). Cell viability 
was found to increase with maturation time particularly with respect to BT 101 and TW-Z. 
Assuming cumulative ion release occurred for each cement, it is possible that, (since cell 
viability increased) the respective concentration of ions released is below the cells toxicity level 
or ions released from the cements aid in cellular metabolism. 
The addition of Ti to Zn-GPCs has increased the fraction of NBO within the glass. This has 
resulted in an increase in Si release after 30 day, a reduction in Sr release and little change 
regarding Zn and Ca release. Cements containing Ti were also found to have a lower initial SA 
than the control cement; however this changed after 7 days, which suggests the Ti cements are 
less soluble or have a more defined set than the control material. CaP surface deposition was 
found on each of the cements at each time period tested. Cell culture testing revealed that TW-Z 
was found to have the highest cell viability than any other cement tested.   
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